These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38335231)

  • 21. Improving TB case notification in northern Uganda: evidence of a quality improvement-guided active case finding intervention.
    Karamagi E; Sensalire S; Muhire M; Kisamba H; Byabagambi J; Rahimzai M; Mugabe F; George U; Calnan J; Seyoum D; Birabwa E
    BMC Health Serv Res; 2018 Dec; 18(1):954. PubMed ID: 30541533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed diagnosis and treatment of tuberculosis in HIV+ patients in Mozambique: A cost-effectiveness analysis of screening protocols based on four symptom screening, smear microscopy, urine LAM test and Xpert MTB/RIF.
    Orlando S; Triulzi I; Ciccacci F; Palla I; Palombi L; Marazzi MC; Giuliano M; Floridia M; Mancinelli S; Mutemba E; Turchetti G
    PLoS One; 2018; 13(7):e0200523. PubMed ID: 30024890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xpert
    Kohli M; Schiller I; Dendukuri N; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012768. PubMed ID: 30148542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrospective Diagnostic Accuracy Study of Abbott RealTi
    Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM
    Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intensified tuberculosis case-finding in HIV-positive adults managed at Ethiopian health centers: diagnostic yield of Xpert MTB/RIF compared with smear microscopy and liquid culture.
    Balcha TT; Sturegård E; Winqvist N; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    PLoS One; 2014; 9(1):e85478. PubMed ID: 24465572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India.
    Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN
    PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Algorithms for Screening for Active Tuberculosis among Individuals with Latent Tuberculosis Infection in a Rural Community in China.
    Xin H; Du Y; Cao X; Wang D; Zhang B; Zhang H; Feng B; He Y; He Y; Quan Z; Liu Z; Yan J; Guan L; Guan X; Shen F; Liu J; Jin Q; Pan S; Gao L
    Microbiol Spectr; 2022 Dec; 10(6):e0296722. PubMed ID: 36445141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xpert MTB/RIF Ultra assay for the detection of Mycobacterium tuberculosis in people with negative conventional Xpert MTB/RIF but chest imaging suggestive of tuberculosis in Dhaka, Bangladesh.
    Biswas S; Uddin MKM; Paul KK; Ather MF; Ahmed S; Nasrin R; Kabir S; Heysell SK; Banu S
    Int J Infect Dis; 2022 Jan; 114():244-251. PubMed ID: 34774779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xpert MTB/RIF Ultra and Xpert MTB/RIF for diagnosis of tuberculosis in an HIV-endemic setting with a high burden of previous tuberculosis: a two-cohort diagnostic accuracy study.
    Mishra H; Reeve BWP; Palmer Z; Caldwell J; Dolby T; Naidoo CC; Jackson JG; Schumacher SG; Denkinger CM; Diacon AH; van Helden PD; Marx FM; Warren RM; Theron G
    Lancet Respir Med; 2020 Apr; 8(4):368-382. PubMed ID: 32066534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Performance of algorithms for tuberculosis active case finding in underserved high-prevalence settings in Cambodia: a cross-sectional study.
    Choun K; Decroo T; Mao TE; Lorent N; Gerstel L; Creswell J; Codlin AJ; Lynen L; Thai S
    Glob Health Action; 2019; 12(1):1646024. PubMed ID: 31500551
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    Kendall EA; Schumacher SG; Denkinger CM; Dowdy DW
    PLoS Med; 2017 Dec; 14(12):e1002472. PubMed ID: 29240766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing new tuberculosis diagnostics: the impact of Xpert(®) MTB/RIF testing on case notifications in Nepal.
    Creswell J; Rai B; Wali R; Sudrungrot S; Adhikari LM; Pant R; Pyakurel S; Uranw D; Codlin AJ
    Int J Tuberc Lung Dis; 2015 May; 19(5):545-51. PubMed ID: 25868022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
    Hodille E; Maisson A; Charlet L; Bauduin C; Genestet C; Fredenucci I; Rasigade JP; Lina G; Dumitrescu O
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):601-605. PubMed ID: 30680567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advancing tuberculosis diagnosis and management in cynomolgus macaques using Xpert MTB/RIF ultra assay.
    Srilohasin P; Warit S; Prammananan T; Smithtikarn S; Kanitpun R; Kaewparuehaschai M; Noradechanon K; Meesawat S; Thakaew N; Sakulwittayasuk N; Kemthong T; Palaga T; Malaivijitnond S; Chaiprasert A
    Sci Rep; 2024 Jan; 14(1):1518. PubMed ID: 38233591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid microbiological screening for tuberculosis in HIV-positive patients on the first day of acute hospital admission by systematic testing of urine samples using Xpert MTB/RIF: a prospective cohort in South Africa.
    Lawn SD; Kerkhoff AD; Burton R; Schutz C; van Wyk G; Vogt M; Pahlana P; Nicol MP; Meintjes G
    BMC Med; 2015 Aug; 13():192. PubMed ID: 26275908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study.
    Kebede W; Abebe G; Gudina EK; Van Rie A
    Sci Rep; 2021 Dec; 11(1):24428. PubMed ID: 34952913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting.
    Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K
    Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Community- based Active Tuberculosis Case Finding in Pastoralist Communities of North-Eastern Uganda.
    Isaac G; Robert EJ; Swabrah N; Gloria N; Okungura PD; Oboth P; Iramiot JS; Nekaka R
    Microbiol Res J Int; 2019 Nov; 29(3):1-10. PubMed ID: 34169184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Practical Value of Xpert MTB/RIF Ultra for Diagnosis of Pulmonary Tuberculosis in a High Tuberculosis Burden Setting: a Prospective Multicenter Diagnostic Accuracy Study.
    Wang G; Huang M; Jing H; Jia J; Dong L; Zhao L; Wang F; Xue Y; Deng Y; Jiang G; Huang H
    Microbiol Spectr; 2022 Aug; 10(4):e0094922. PubMed ID: 35876568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Xpert MTB/RIF testing introduction and favorable outcome predictors for tuberculosis treatment among HIV infected adults in rural southern Mozambique. A retrospective cohort study.
    Nacarapa E; Muchiri E; Moon TD; Charalambous S; Verdu ME; Ramos JM; Valverde EJ
    PLoS One; 2020; 15(3):e0229995. PubMed ID: 32150595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.